Lepidic-Predominant Lung Adenocarcinoma

1

Review clinical trials related to Lepidic-Predominant Lung Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma

This study evaluates whether a 7-day ketogenic dietary regimen before 2-\[18F\]FDG PET/CT can improve the diagnostic accuracy of imaging in adults with suspected or histologically confirmed lepidic-predominant lung adenocarcinoma (LPA). LPA frequently shows low glucose metabolism and may yield false-negative FDG PET/CT results. Approximately 30 participants will undergo a tailored ketogenic diet for 7 days before PET/CT. Imaging results will be compared with histopathology and additionally assessed against literature-reported diagnostic performance and a matched retrospective institutional cohort.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fondazione del Piemonte per l'OncologiaUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Written informed consent. [+6]

Not suitable for prolonged imaging procedures. [+8]